PLOD1 and polycystic ovary syndrome: Compared with the control group, the PCOS-IR group exhibited a broad spectrum of metabolic and endocrine changes, such as significantly elevated TG levels, AMH, and testosterone, an increased LH to FSH ratio and notably decreased FSH, and PRL levels.